Documente Academic
Documente Profesional
Documente Cultură
NURSING
RALPH R. DELOS SANTOS
BACHELOR OF SCIENCE IN NURSING
Pamantasan ng Lungsod ng Maynila
4th Placer December 2012 NLE
DOCTOR OF MEDICINE (ongoing)
PLM College of Medicine
FORMER EMERGENCY AND TRAUMA STAFF NURSE
Emergency and Trauma Department
Gat Andres Bonifacio Memorial Medical Center
City Government of Manila
FUNCTIONAL ANATOMY OF THE HEART
ANATOMIC LAYERS OF THE HEART
EPICARDIUM
Outer most layer and
continuous with the
visceral pericardium
MYOCARDIUM
Muscular layer of the heart
which is responsible for
the contractility and
pumping action the heart.
ENDOCARDIUM
Lines the inner portion of
the heart and is continuous
with the lining of the valve
leaflets
BLOOD SUPPLY OF THE HEART
CLINICAL ANATOMY
PHYSIOLOGIC CONCEPTS
INOTROPY
Refers to the contractility of the heart regardless of
preload
Influenced by sympathetic stumulation
Agents which increase the contractility of the heart are
called POSITIVE INOTROPICS (e.g. Digoxin)
CHRONOTROPY
Refers to the heart rate (N: 60-100 bpm)
Agents which decrease the heart rate are called NEGATIVE
CHRONOTROPICS (e.g. Beta Andrenergic Blockers)
DROMOTROPY
Refers to the conduction velocity within the heart
PHYSIOLOGIC CONCEPTS: CARDIAC CYCLE
SYSTOLE: ATRIAL
Phase of contraction preceded by depolarization
of the SA Node
Depolarization of the Atrial Cells (P wave)
Contraction of the Atrium
The Atrial Kick
PHYSIOLOGIC CONCEPTS: CARDIAC CYCLE
SYSTOLE: VENTRICULAR
Occurs after firing from the SA resulting to atrial
contraction
Impulse travels from SA to AV (with a delay or the
PR Interval)
Impulse from SA AV depolarizes the Ventricular
Cells (QRS Complex)
Contraction of the Ventricles
Effects: Closure of the AV Valves, Opening of the
Aortic and Pulmonic Valves
PHYSIOLOGIC CONCEPTS: CARDIAC CYCLE
DIASTOLE: VENTRICULAR
Preceded by repolarization (T wave)
Ventricles relax (AV Valves open to fill
the ventricles as Atria contracts, as
explained earlier. Pulmonic and Aortic
Valves close to allow filling and
premature leaking)
The cycle repeats.
PHYSIOLOGIC CONCEPTS
PRELOAD
Degree of stretch at the end of diastole
Determined by End-Diastolic Volume
Increases with increased Venous Return
AFTERLOAD
Resistance against the contracting
ventricles of the heart
Pressure required to open the AORTIC VALVE
PHYSIOLOGIC CONCEPTS
STROKE VOLUME
Amount of blood ejected from the
ventricle per heart beat
CARDIAC OUTPUT
Amount of blood pumped from the
ventricle per unit of time (approx.
5L/min)
PHYSIOLOGIC CONCEPTS
SKIN
Clubbing of fingers
Edema
Pallor and Cyanosis
EVALUATION OF EDEMA
(for CHF by Guelph General Hospital)
SCORE DEPTH CHARACTER DISTORTION DISAPPEARANCE
XANTHELASMA PALPEBRARUM
BASIC PRINCIPLES OF PHYSICAL EXAMINATION
LABORATORY
Complete Blood Count
Detection of infection
Hematocrit can be evaluated
for anemia
DIAGNOSTICS IN CARDIOVASCULAR NURSING
LABORATORY
Coagulation Studies
PT (11-14 s), PTT (25-35 s),
INR (0.8-1.2)
INR Target: 2.0-3.0
PT Target: 1.5-2.0 x control
DIAGNOSTICS IN CARDIOVASCULAR NURSING
LABORATORY
Serum Lipid
Cholesterol
Desirable: < 200 mg/dL
Borderline-high: 200 239
mg/dL
High: 240 mg/dL
DIAGNOSTICS IN CARDIOVASCULAR NURSING
LABORATORY
Serum Lipid
LDL-C
Optimal: < 100 mg/dL
Near
or Above Optimal: 100 129
mg/dL
Borderline-high: 130 -159 mg/dL
High LDL-C: 160 189 mg/dL
Very High: 190 mg/dL
DIAGNOSTICS IN CARDIOVASCULAR NURSING
LABORATORY
Serum Lipid
HDL-C
Low: < 40 mg/dL
High: 60 mg/dL
DIAGNOSTICS IN CARDIOVASCULAR NURSING
LABORATORY
Serum Electrolytes
Na+
K+
Mg 2+
Ca2+
PO43-
OUTLINE OF DISORDERS
DYSRHYTHMIA
CORONARY ARTERY DISEASES
VALVULAR HEART DISEASES
CARDIOMYOPATHY
HEART FAILURE
INFECTIOUS AND INFLAMMATORY HEART DISEASES
PERIPHERAL VASCULAR DISEASES
HYPERTENSION AND ITS MANAGEMENT
Ikaw ang nagpatibok sa
puso ko, ikaw din ang
nagturo dito na maguluhan
at tuluyang tumigil.
(Antidysrhythmic)
DIAGNOSE.
THE CARDIAC CIRCUIT
THE NORMAL EKG
1: 300 BPM 6: 50
2: 150 7: 43
3: 100 8: 37
4: 75 9: 33
5: 60 10: 30
BASICS OF INTERPRETATION
SINUS BRADYCARDIA
SINUS TACHYCARDIA
SINUS BRADYCARDIA
HR < 60 bpm, slow SA firing
Usually benign in cases of athletics
Secondary to vagal stimulation, Increased ICP
SE of medications (Digitalis, Propranolol)
A drop in the HR can cause syncope
Mx: Atropine 0.5-1 mg IV push
Nx: Avoid vagal stimulation
SINUS TACHYCARDIA
HR > 100 bpm
Canbe caused by fever, hypermetabolism,
anxiety, and acute blood loss
SE of sympathomimetics
Decreased diastolic filling time
Mx: Beta Adrenergic Antagonists (Blockers)
ATRIAL DYSRHYTHMIAS
MEDICAL MANAGEMENT
Restorationof sinus rhythm using medications
or cardioversion
Medications for dysrhythmia are usually given
after 4 to 6 weeks of anticoagulation
CARDIOVERSION
Anelective procedure for dysrhythmias caused
by reentry
Allows the SA to resume its pacemaker role
Synchronized with the QRS complex to avoid
discharge during repolarization
A QRS COMPLEX MUST BE PRESENT
Low voltage: 50 100 J
Done under analgesia or sedation
NURSING CARE IN CARDIOVERSION
BEFORE
Baseline EKG for dysrhythmia type
Full explanation of the procedure
Patient should fast, with normal electrolytes
For patients receiving Digitalis, obtain level
INR 2.0 3.0 after 4 -6 weeks of anticoagulation
Done at bedside, secure emergency equipment
Start IV for preoperative medications.
NURSING CARE IN CARDIOVERSION
DURING
Setthe biphasic machine within a range of 50
200 J
Turn synchronizer to ON
Clear the patients area
Deliver the shock
Reassess rhythm, PR, BP, Oxygen Saturation and
airway
NURSING CARE IN CARDIOVERSION
AFTER
Immediately assess EKG, Pulse, BP, Respiratory
Status
Address possibility of ventricular dysrhythmias
Monitor EKG and VS continuously for at least 2
hours
SUCCESSFUL: Back to Sinus Rhythm
Protect airway while patient is still sedated
ATRIAL FLUTTER
Conduction defect of the atria
AR: 250-400 bpm
VR: 75-150 bpm
Fires faster than what AV node can accommodate
and transmit to the ventricles
Can result to VFib
SAW-TOOTH PATTERN
Tx: Cardioversion, Diltiazem, Verapamil, Beta-
Blockers, Anticoagulation, IBUTILIDE
VENTRICULAR DYSRHYTHMIAS
MANAGEMENT
START CPR! immediately until defibrillator is
engaged
Defibrillate up to THREE TIMES IF NEEDED.
200 J then 300 J then 360 J
VENTRICULAR ASYSTOLE
Absent QRS
CPR as immediate management
Epinephrine 1 mg IV bolus q 3-5 min for 3 doses
(no routine Atropine)
Identification and correction of etiology
Inability to respond terminates the code.
AHA 2015 BASIC LIFE SUPPORT
HIGHLIGHTS
KEY POINTS:
Activation of emergency response can be
through mobile telephone, so you dont need
to leave the victims side
Still C-A-B
30 chest compressions : 2 breaths is lone
rescuer
Chest compression from at least 100/min
(2010) to 100 120/min
AHA 2015 BASIC LIFE SUPPORT
HIGHLIGHTS
KEY POINTS:
Depth of compression: at least 2 in (5 cm) but
not greater that 2.4 in (6 cm)
Allow full chest recoil after each compression
Minimize pauses (interruption should be < 10
seconds)
Bystanders may administer NALOXONE.
Ventilation
Rate: 1 breath (delivered in 1
second, observe for chest rise) every 6 seconds
(10 breaths per minute)
AHA 2015 ADVANCED CARDIOVASCULAR
LIFE SUPPORT HIGHLIGHTS
KEY POINTS:
Back to EPINEPHRINE
Lidocaine after ROSC in pVT/VF
Useof Beta-Blockers is associated with better
outcomes
ETCO2 > 10 mm Hg after 20 minutes of
resuscitation as component of prediction of
success
TargetTemperature: 32 36 centigrade for at
least 24 Hours
AHA 2015 ADVANCED CARDIOVASCULAR
LIFE SUPPORT HIGHLIGHTS
KEY POINTS:
Whento prognosticate: 72 HOURS AFTER
RETURN TO NORMOTHERMIA
Organ Donation (Liver and Kidney)
DEFIBRILLATOR
Deliversbiphasic current thorough paddles to
completely depolarize the heart producing a
transient asystole
CARE OF CLIENTS UNDERGOING
BEFORE DEFIBRILLATION
Determine responsiveness, activate emergency
response
Call for defibrillator and E-cart
ASSESSMENT: A-B-C
CPR until defibrillator is in place
Verify EKG in 2 leads
Remove NTG patch (if present)
CARE OF CLIENTS UNDERGOING
DURING DEFIBRILLATION
Lubricate paddle with electrode gel
Do not over-apply the gel
Paddle Placement:
Paddle 1 (held by left hand): 2nd ICS Right of
Sternum
Paddle 2 (held by right hand): Apex
Call for clearance!
CARE OF CLIENTS UNDERGOING
DEFIBRILLATION
AFTER
Immediately assess the EKG and pulse
May be repeated if unsuccessful
(Refer TO AHA 2015 Recommendations)
THE ATRIOVENTRICULAR BLOCKS
FIRSTDEGREE
SECOND DEGREE
MOBITZ I (WENCKEBACH
PHENOMENON)
MOBITZ II
THIRD DEGREE
FIRST DEGREE
Slowed SA AV transmission
Seen as prolonged P-R Interval
Relatively
benign and requires no
management
Ifcaused by Digitalis, medication should be
discontinued
SECOND DEGREE AV BLOCK: MOBITZ I
(WENCKEBACH PHENOMENON)
DEMAND
Fires only if HR goes below the
predetermined rate
Paces and senses
POWER SOURCES
EKG
Stress Test until reaching the 85% maximal
heart rate
Coronary Angiography
CXR
MEDICAL MANAGEMENT
TROPONIN (T, I, C)
Usedmore frequently and routinely to
identify myocardial infarction
The GOLD STANDARD
THE SERUM MARKERS
OTHER MARKERS
LDH
AST
MYOGLOBIN
SO SUDDENLY I HAVE THIS
PATIENT COMPLAINING OF
CHEST PAIN AND THIS IS VERY
TYPICAL OF MYOCARDIAL
INFARCTION
WHAT SHOULD I DO?
AS A GENERAL RULE!
A PATIENT WITH MANIFESTATION OF
MYOCARDIAL INFARCTION SHOULD:
Assume the DOOR-TO-NEEDLE approach
in LESS THAN 30 MINUTES. Contact EMS!
Fromthe onset of chest pain, patient
should be brought within 30 MINUTES for
THROMBOLYTIC THERAPY
ORwithin 1 HOUR for INTERVENTIONAL
CARDIOLOGY
SO WHEN IS AN INDICATED
MANAGEMENT INDICATED?
DETERMINE THE TYPE OF AMI
If there is the persistence of ST-
Segment Elevation, we
immediately reperfuse.
Thrombolysis
Percutaneous Intervention
If NSTEMI vs Unstable Angina,
usually receives anti-ischemic
management.
CLINICAL PHARMACOLOGY
PHARMACOTHERAPEUTICS
MEDICAL MANAGEMENT
Analgesics (Morphine Sulfate)
Intravenous Nitrates (ISDN Drip)
Beta Blockers (Metoprolol)
ACE Inhibitors (Captopril/Enalapril)
CLINICAL PHARMACOLOGY
PHARMACOTHERAPEUTICS
MEDICAL MANAGEMENT
Antiplatelet (ASPIRIN, Clopidogrel,
Ticlopidine)
Anticoagulant (Heparin, Enoxaparin,
Fondaparinux)
Other Cardio-supportive Medications to
Combat Shock (Dobutamine, Dopamine)
Antidysrhythmics
NOTES ON THROMBOLYSIS
Used to dissolve existing clots
-ASE (Streptokinase, Urokinase, Alteplase [t-PA])
CONTRAINDICATIONS:
Cranial Pathology or Trauma within past 3 mo.
Previous allergic reaction to the medications
Recent Streptococcal infection or received
Streptokinase in the past 6-12 months
COMPLICATIONS OF MYOCARDIAL INFARCTION
DYSRHYTHMIA
Cause of 40-50% of deaths post-AMI (MOST
COMMON CAUSE OF DEATH AFTER AMI)
Monitor for fatal PVCs, SVT, Heart Blocks
CARDIOGENIC SHOCK
Cause of 9% of deaths post-AMI
Decreased myocardial contraction leading to
decline in Cardiac Output and BP
COMPLICATIONS OF MYOCARDIAL INFARCTION
MYOCARDIAL NECROSIS
Causes Rupture of Heart Muscle and VSD
COMPLICATIONS OF MYOCARDIAL INFARCTION
PERICARDITIS
Due to inflammatory mechanism
Usually 2-4 days after AMI
DRESSLERS SYNDROME:
Late appearing pericarditis (6 weeks to months)
Autoimmune cause is suggested
Avoid anticoagulants which may precipitate
Cardiac Tamponade
CORONARY ARTERY BYPASS GRAFTING
Done if vessel occlusion is 70% (60% if left main
coronary artery)
The patient is first put on CARDIOPULMONARY
BYPASS:
An Extracorporeal Machine takes over the
function of the heart and lungs
Hemodilution: Blood is diluted using crystalloid
Hypothermia: 28-36 degrees centigrade
Heparinized (Anticoagulated)
CORONARY ARTERY BYPASS GRAFTING
Done if vessel occlusion is 70% (60% if left main
coronary artery)
The patient is first put on CARDIOPULMONARY BYPASS
after Cardioplegia.
An Extracorporeal Machine takes over the function of
the heart and lungs
Hemodilution: Blood is diluted using isotonic crystalloid
Hypothermia: 28-36 degrees centigrade
Heparinized (Anticoagulated)
CORONARY ARTERY BYPASS GRAFTING
PROLAPSE
REGURGITATION
STENOSIS
MITRAL VALVE PROLAPSE
Pathophysiology
Ballooning of the leaflet to the
atrium during systole
Blood backflows from the left
ventricle to the left atrium
Manifestations
SOB
Light-headedness
Syncope
Palpitation
MITRAL VALVE PROLAPSE
Diagnostic Findings
Murmur: Systolic Click
Crackles
Confirmed by Echocardiography
MITRAL VALVE PROLAPSE
Medical-Surgical Management
Symptomatic approach
Calcium-channel blockers, Beta-blockers
Mitral Valve Repair / Replacement
Nursing Management
Instruct patient to avoid stimulants
Educatepatient regarding need for
prophylactic antibiotics during invasive
procedures
MITRAL REGURGITATION
Pathophysiology
MOST COMMON
Associated with MI, papillary
muscle failure, heart
enlargement.
Left Ventricular to Atrial
Backflow
Clinical Manifestations
Dyspnea
Fatigue
Pulmonary Congestion
MITRAL REGURGITATION
Diagnostic Findings
Systolic high-pitched blowing murmur at apex
Confirmed by Echocardiography
Medical-Surgical Management
Same as that of CHF
MV Replacement of Valvuloplasty
MITRAL STENOSIS
Pathophysiology
Narrowing of the opening of
the mitral valve
Inability of blood to flow
from LA LV
Backflow effects
Clinical Manifestations
DOB FIRST SYMPTOM!
Fatigue
Left-sided Heart Failure-
like
MITRAL STENOSIS
Diagnostic Findings
Low-pitched rumbling diastolic murmur
Confirmed by Echocardiography
Medical-Surgical Management
Antibiotic prophylaxis
Anticoagulant Therapy
Valvuloplasty / Valve Replacement Surgery
AORTIC REGURGITATION
Pathophysiology
Blood from the aorta backflows
to the LV during diastole
Diastolic Overload: Blood
entering the LV from LA, plus,
blood flowing backwards from
aorta to LV.
Clinical Manifestations
Aortic insufficiency: Fatigue
Forceful heartbeats
LV Failure
AORTIC REGURGITATION
Assessment and Diagnostic Findings
High-pitched diastolic murmur
Widened pulse pressure
Water-Hammer Pulse
Medical-Surgical Management
Prophylactic Antibiotics for invasive
procedures
Valvuloplasty
/ Valve Replacement
TREATMENT OF CHOICE
AORTIC STENOSIS
Pathophysiology
Progressive narrowing of the valve
orifice
Inability of blood to flow through the
aortic valve
LV overload and hypertrophy
Clinical Manifestations
Usually asymptomatic
Fatigue
Dyspnea
Ischemic effects to the myocardium
Possible MI
AORTIC STENOSIS
Medical-Surgical Management
Prophylactic Antibiotics
Definitive treatment is Valve Replacement
Surgery
NURSING MANAGEMENT OF
VALVULAR HEART DISEASES
Assess
understanding of the progressive
nature of the diseases.
Encourage client to report new symptoms
or change in the previously experienced
symptoms
Emphasize the importance of prophylactic
antibiotics before any invasive procedures
Educate patient regarding predilection of
bacteria to diseased heart valves
NURSING MANAGEMENT OF
VALVULAR HEART DISEASES
MonitorVS, obtain baseline. Include
assessment for the presence of murmur and
adventitious breath sounds
Patient may feel clicks due to prosthesis
Emphasize need to comply to medications
and dietary modification
Weigh daily and report a gain of 2 pounds
/ day or 5 pounds / week.
CARDIOMYOPATHY
HYPERTROPHIC CARDIOMYOPATHY
DILATED CARDIOMYOPATHY
RESTRICTIVE CARDIOMYOPATHY
GENERAL PATHOPHYSIOLOGY OF
CARDIOMYOPATHIES
All end-up in or culminate in impaired
cardiac output
Decreased stroke volume leads to
sympathetic and RAAS activation.
Lead to increased systemic vascular
resistance and sodium retention
DILATED CARDIOMYOPATHY
MOST COMMON
Characterized by significant dilation of the
ventricles without increase in wall thickness
Decreased muscular elements
Poorsystolic function and more blood is left
in the heart after contraction
Results in valve regurgitation
Associated
with PREGNANCY (Peripartum
Cardiomyopathy)
DILATED CARDIOMYOPATHY
DILATED CARDIOMYOPATHY
COMPLICATIONS
Usually to ineffective pumping of the
heart with SNS activation
Development of dysrhythmia
Blood pooling and thrombosis
HYPERTROPHIC CARDIOMYOPATHY
The heart increases in size and mass, especially
the septal portion
Increased mass reduces cavity or space (caliber)
inside the heart
Septal hypertrophy blocks flow from Left Atrium
as well as outflow from Left Ventricle
Diastolic (filling) function of the heart is
impaired.
Most common manifestation is DYSPNEA (90%)
This has genetic predisposition
RESTRICTIVE CARDIOMYOPATHY
SURGICAL MANAGEMENT
HF can be addressed by Cardiac Transplantation
PRINCIPLES OF
CARDIAC TRANSPLANTATION
TEACHING MOMENT.
ASSESSMENT AND DIAGNOSTIC FINDINGS
ASSESSMENT DIAGNOSTICS
Patientsusually become Ancillary
aware when they are CXR, 12-Lead EKG,
already symptomatic Echocardiography
Mayco-exist with other Laboratory
diseases
Routine Chemistry
PE:Signs and Symptoms
Electrolytes, BNP
of Congestive Heart
Failure
CLINICAL PHARMACOLOGY
PHARMACOTHERAPEUTICS
NURSING DIAGNOSES
Activity
intolerance r/t to imbalance
between oxygen supply and demand
Excess fluid volume r/t sodium intake
Anxiety r/t breathlessness
NURSING MANAGEMENT
INTERVENTIONS
Promote adequate rest and light activity,
stop if necessary
3-5 min, 1-4x a day of activity
Monitor fluid volume, weight gain.
Low-sodium diet, be aware of other sources
of sodium
During rest, head elevation 20-30 cm or 8-
10 in blocks, reduces preload.
CARDIOGENIC SHOCK
INFLAMMATORY DISEASE
Pericarditis
Myocarditis
RHEUMATIC FEVER
Associated with Group A Beta Hemolytic
Streptococcal Infection
Immunologic mechanism
Clinical Manifestations originate from immune
reaction to underlying infectious pathology
Results to valvular impairment
May present as valvular heart disease.
MOST COMMON AGE: Between 6 15 years old
Prevented by prompt treatment of
tonsillopharyngeal infections using antibiotics and
elective tonsillectomy
RHEUMATIC FEVER
Associated with Group A Beta Hemolytic
Streptococcal Infection. Appears 1-6 weeks after.
Immunologic mechanism
Clinical Manifestations originate from immune
reaction to underlying infectious pathology
Results to valvular impairment
May present as valvular heart disease.
MOST COMMON AGE: Between 6 15 years old
Prevented by prompt treatment of
tonsillopharyngeal infections using antibiotics and
elective tonsillectomy
PATHOGENESIS
Diffuse, proliferative, and exudative
inflammatory process
Involves the heart, joints,
subcutaneous tissues, CNS, and skin
Has underlying immune mechanism
Affects valves causing a button-hole
like deformity.
Results to possible pulmonary
complication
SALIENT CLINICAL FEATURES
CARDITIS/PANCARDITIS
MOST DESTRUCTIVE consequence
Causes Heart Blocks, Valve Diseases
MIGRATORY POLYARTHRITIS
MOST COMMON FINDING
Affects large joints
Responds to salicylates
SALIENT CLINICAL FEATURES
CARDITIS/PANCARDITIS
MOST DESTRUCTIVE consequence
Causes Heart Blocks, Valve Diseases
Presence of ASCHOFF BODIES
MIGRATORY POLYARTHRITIS
MOST COMMON FINDING
Affects large joints
Responds to salicylates
ASCHOFF BODY
ANITSCHKOW CELL (CATERPILLAR CELL)
SALIENT CLINICAL FEATURES
SYNDENHAMS CHOREA (Dance of St. Vitus)
Disorder of basal ganglia
Aimless involuntary movements
ERYTHEMA MARGINATUM
Rash seen on the trunk
Application of heat intensifies the rash
SUBCUTANEOUS NODULES
Painless, free nodules of the knees, knuckles,
and elbow seen usually only in children
JONES CRITERIA
MAJOR MINOR (CLINICAL)
Carditis Previous RF/RHD
Migratory Polyarthritis Arthralgia
Sydenhams Chorea Fever
Erythema Marginatum MINOR (LABORATORY)
Subcutaneous Nodules Increased ESR, CRP, WBC
Prolonged PR Interval
Provide Comfort
Administer salicylates as ordered
Emphasize Hygiene
INFECTIVE ENDOCARDITIS
Infectious and inflammatory process of the
endocardium, especially the valves
Can be SUBACUTE which develops over
several weeks or months caused by
Streptococcus viridans
Can be ACUTE which appears over days or
weeks caused by Staphylococcus aureus
Can affect normal, damaged, and replaced
valves (Prosthesis)
INFECTIVE ENDOCARDITIS
Blood culture
Complete Blood Count
Cardiac Examination (e.g. presence of murmur)
EKG and Echocardiography
MANAGEMENT
BECKS TRIAD
Hypotension
Jugular Venous Distention
Muffled, Distant Heart Sound
CARDIAC TAMPONADE
OTHER SALIENT MANIFESTATION
Elevated Venous Pressures
Right and Left Heart Failure Signs and Symptoms
Pulsus Paradoxus
MANAGEMENT
Periocardiocentesis
PERICARDIOCENTESIS
PERIPHERAL VASCULAR DISEASES
Diseasesinvolving blood vessels (arteries,
veins, and their branches)
Arterial
diseases result to loss of oxygen
and nutrient supply to distal areas
Venousdiseases result to inability to
reabsorb fluid (together with the
lymphatics) and stasis of blood in the distal
areas contributing to a possible
thromboembolic formation
PERIPHERAL VASCULAR DISEASES
ASSESSMENT FINDINGS
Intermittent Claudication
Most important subjective manifestation of
chronic arterial occlusive disease
Crampy pain in the extremities consistently
reproduced by some degree of activity or exercise
Result of oxygen lack
Seen if 50-75% of arterial lumen is obstructed
Pain occurs one joint level below the disease
process
PERIPHERAL VASCULAR DISEASES
ASSESSMENT FINDINGS
Rest Pain
Limb-threatening condition
Worse at night
Extremity should be lowered
Decreased Pulses
PULSE GRADING
3+ BOUNDING
2+ NORMAL
1+ WEAK
0 - ABSENT
PERIPHERAL VASCULAR DISEASES
CT Angiography
MRI
Doppler UTZ
Interventional Cardiology: Angiography
Ankle-Brachial Index
DIAGNOSTICS
CT Angiography
MRI
Doppler UTZ
Interventional Cardiology: Angiography
Ankle-Brachial Index
ANKLE BRACHIAL INDEX
ANKLE BRACHIAL INDEX
INTERPRETATION
0.9 (0.9 to 1.3) NORMAL
<0.89 to >0.60 MILD PAD
<0.59 to >0.40 MODERATE PAD
<0.39 SEVERE PAD
NURSING MANAGEMENT: THE PATIENT
WITH ARTERIAL INSUFFICIENCY
ASSESSMENT
Complete health history, identify risk factors
Identify specific manifestations, color, pulse
changes, and ulcers
NURSING DIAGNOSES
Ineffective peripheral tissue perfusion r/t
compromised circulation
Risk for impaired skin integrity r/t compromised
circulation
Deficient knowledge regarding self-care activities
INTERVENTIONS
Positioning below the level of the heart
Head elevation of about 15 cm, reclining
chair, sit with feet resting on the floor
Isometric exercises to promote circulation
Monitor for pain attacks
Apply warmth to promote flow
INTERVENTIONS
Avoid excessive exposure to cold adequate
clothing
If patient chills, warm bath or drink is helpful
In providing warmth, temperature of heat
source should not exceed body temperature
INTERVENTIONS
Instruct
patient to test bath water, use
thermometer (32.2 to 35 centigrade)AVOID HOT-
WATER BOTTLES and HEATING PADS
Applyheating pads on the abdomen to trigger
reflex vasodilation and this is safer than direct
application.
INTERVENTIONS
Avoid nicotine
Avoid trauma to ischemic sites
Never go barefoot
Avoid high heels and pointed shoes
Wear sturdy, well-fitting shoes or slippers
to prevent foot injury and blisters
Useneutral soaps to prevent
drying/cracking of skin, may apply lotion
but not between toes
INTERVENTIONS
Fingernails and toenails should be
carefully trimmed straight across and
sharp edges are filed to follow contour
Thick/brittle nails cannot be trimmed
safely consult a podiatrist!
Corn/calluses should be removed by
professionals
THROMBOANGIITIS OBLITERANS
(BUERGERS DISEASE)
Recurring
inflammation of
intermediate and
small arteries and
veins of the
extremities
Highly-associated
with smoking
Believed to be a form
of vasculitis
Symptoms
Major symptom: PAIN
Foot cramps, instep claudication
Relieved by rest
Signs
Intense rubor (reddish-blue
discoloration)
Absent pedal pulses but normal
proximal pulses
May progress to ulceration
Management
Vasodilators
Treatment and debridement of ulcers
Prevention of spread of infection
AVOID SMOKING.
AMPUTATION
CXR
Transesophageal Echocardiography
CT Scan
MEDICAL-SURGICAL MANAGEMENT
Treated by surgical repair
Aggressive BP control
Systolic BP maintained at 100-120 mm Hg
THERAPEUTICS
Hydralazine
Esmolol
Atenolol
SURGICAL
Repair the aneurysm, vascular grafting
#nursinggoals
Prevent rupture
BP monitoring
Strict UO monitoring
Do not palpate the pulsating mass!
Provide rest and comfort
ABDOMINAL AORTIC ANEURYSM
Still,
atherosclerosis is the most common
cause
PATHOPHYSIOLOGY
All aneurysms involve the tunica media
Prone to weakness
Hypertension is a risk
MANIFESTATIONS
Time-Bomb
Apparent pulsating mass
ASSESSMENT
Venous Thrombosis
Deep Vein Thrombosis
Thrombophlebitis
Phlebothrombosis
VENOUS DISORDERS
MANAGEMENT:
Preventive through exercise
Sequential Compression Device (e.g.
Kendall) Not used in known DVT
Pharmacologic Methods
ACUTE: THROMBOPHLEBITIS
MANAGEMENT:
Preventive through exercise
Sequential Compression Device (e.g.
Kendall) Not used in known DVT
Used for longer than 24H
Removed BID to inspect skin and to
allow perspiration to evaporate
Pharmacologic Methods
ACUTE: THROMBOPHLEBITIS
ASSESSMENT AND DIAGNOSTICS
MANIFESTATIONS
Edema
Pigmentation
Pain
Symptoms are more apparent in the evening
Ulcers
MANAGEMENT
Elevate the legs, 15-30 mins x 2 H
When sleeping elevate the foot about 15
cm
Walking should be encouraged
Avoid leg crossing, tight garments
Compression stocking: Apply after leg
raising when the level of pooled blood is
reduced
Manage Leg Ulcers Antibiotics
HYPERTENSION
TYPES
Primary 95% (approx.)
Secondary 5% (approx.)
HYPERTENSIVE CRISES
Hypertensive
Emergency Necessitates
IMMEDIATE lowering
Hypertensive Urgency Lowered within a
few hours
HYPERTENSION
VESSEL CHANGES
Vascularchanges lead to
reduced flow to important
organs (e.g. heart, brain,
kidneys, and retina)
JNC 7
MODIFIABLE RISK FACTORS
Diabetes
Stress Level
Obesity
Nutrient consumption (e.g. Sodium)
Substance Abuse
FIN.